Reports for RIVASTIGMINE

Ingredient

RIVASTIGMINE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-RIVASTIGMINE 1.5MG CAPSULE Resolved 2017-09-04 2019-10-15 20900
APO-RIVASTIGMINE 1.5MG CAPSULE Resolved 2022-11-27 2023-03-09 175898
APO-RIVASTIGMINE 1.5MG CAPSULE Resolved 2023-07-21 2024-01-05 199518
APO-RIVASTIGMINE 1.5MG CAPSULE Actual shortage 2024-03-08 2024-03-22 221729
APO-RIVASTIGMINE 3MG CAPSULE Resolved 2019-06-12 2019-10-07 86336
APO-RIVASTIGMINE 3MG CAPSULE Resolved 2021-07-05 2021-12-03 141854
APO-RIVASTIGMINE 3MG CAPSULE Resolved 2023-09-28 2024-01-05 205501
APO-RIVASTIGMINE 4.5MG CAPSULE Resolved 2017-03-11 2017-05-18 487
APO-RIVASTIGMINE 4.5MG CAPSULE Resolved 2018-01-22 2018-01-22 36947
APO-RIVASTIGMINE 4.5MG CAPSULE Resolved 2018-01-22 2018-03-27 36949

Showing 1 to 10 of 39

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MINT-RIVASTIGMINE 1.5MG CAPSULE Discontinued 2017-06-21 2017-07-01 13562
MINT-RIVASTIGMINE 3MG CAPSULE Discontinued 2017-06-21 2017-07-01 13556
MINT-RIVASTIGMINE 4.5MG CAPSULE Discontinued 2017-06-21 2017-07-01 13565
MINT-RIVASTIGMINE 6MG CAPSULE Discontinued 2017-06-21 2017-07-01 13559

Showing 1 to 4 of 4